Institutional Ownership Protalix Bio Therapeutics, Inc. (PLX)
This table provides information about the institutional ownership of Protalix Bio Therapeutics, Inc. (PLX). We have compiled data on the 82 institutions that hold shares in the stock, with a total of 10.6 Million shares, which have been reported (via 13F filing form) to have a value of $19.6 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Opaleye Management Inc.
Boston, MA |
Nov 14, 2025 Q3 2025 |
2,580,556
shares
|
$4.8 Million
0.96% of portfolio
|
Q3 2025
New holding
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2025 Q3 2025 |
1,315,400
shares
|
$2.45 Million
0.0% of portfolio
|
Q3 2025
Reduced 18.55%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
902,459
shares
|
$1.68 Million
0.0% of portfolio
|
Q3 2025
Reduced 16.42%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
819,777
shares
|
$1.52 Million
0.0% of portfolio
|
Q3 2025
Reduced 0.79%
|
|
|
Stratos Wealth Partners, Ltd.
|
Nov 06, 2025 Q3 2025 |
500,000
shares
|
$930,000
0.01% of portfolio
|
Q3 2025
Added 42.86%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
498,547
shares
|
$927,297
0.0% of portfolio
|
Q3 2025
Added 12.22%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
464,421
shares
|
$863,823
0.0% of portfolio
|
Q3 2025
Reduced 4.2%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Nov 13, 2025 Q3 2025 |
400,398
shares
|
$744,740
0.0% of portfolio
|
Q3 2025
Reduced 19.31%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
333,171
shares
|
$619,698
0.0% of portfolio
|
Q2 2024
Reduced 89.94%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
190,276
shares
|
$353,913
0.0% of portfolio
|
Q3 2025
Added 153.19%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Nov 14, 2025 Q3 2025 |
189,100
shares
|
$351,726
0.01% of portfolio
|
Q1 2025
Added 4.24%
|
|
|
Diametric Capital, LP
Boston, MA |
Nov 13, 2025 Q3 2025 |
179,984
shares
|
$334,770
0.2% of portfolio
|
Q3 2025
Added 25.62%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
175,070
shares
|
$325,630
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Commonwealth Equity Services, LLC
|
Oct 22, 2025 Q3 2025 |
171,772
shares
|
$319,495
0.0% of portfolio
|
Q3 2025
Reduced 12.72%
|
|
|
Evergreen Capital Management LLC
Bellevue, WA |
Oct 28, 2025 Q3 2025 |
171,338
shares
|
$318,688
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
150,829
shares
|
$280,541
0.0% of portfolio
|
Q3 2025
Added 47.61%
|
|
|
Main Street Financial Solutions, LLC
|
Nov 14, 2025 Q3 2025 |
129,100
shares
|
$240,126
0.02% of portfolio
|
Q3 2025
New holding
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
101,798
shares
|
$189,344
0.0% of portfolio
|
Q3 2025
Reduced 19.82%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
90,188
shares
|
$167,749
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Xtx Topco LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
85,841
shares
|
$159,664
0.01% of portfolio
|
Q3 2025
Added 16.51%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2025 Q3 2025 |
72,922
shares
|
$135,634
0.0% of portfolio
|
Q3 2025
Reduced 75.58%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
71,037
shares
|
$132,128
0.0% of portfolio
|
Q3 2025
Reduced 84.63%
|
|
|
Wolverine Trading, LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
70,394
shares
|
$130,932
0.0% of portfolio
|
Q3 2025
Added 187.23%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2025 Q3 2025 |
65,617
shares
|
$122,047
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 06, 2025 Q3 2025 |
65,194
shares
|
$121,260
0.0% of portfolio
|
Q3 2025
Reduced 6.59%
|
|